STAT+: Launch prices for new medicines dipped slightly last year but remain high, analysis finds
The median net price for 202 newly launched medicines rose by 35%, to $257,000 last year from $173,000 in 2022.
Sourcing & attribution. Newseze provides AI-curated summaries, narrative framing, and editorial analysis. The underlying reporting was contributed by STAT News; tap “Open original source” above to read their full reporting and support the contributing newsroom directly.
Newseze's algorithm reads the story and answers your question — calmly, factually, with source attribution. No comments, no flame wars — just answers.
No questions yet. Be the first.
Answers reflect Newseze's editorial framework applied under fair use (17 U.S.C. § 107). Not financial, legal, medical, or tax advice. Hate speech and racial slurs are blocked.
Related stories
Why it mattersIsomorphic Labs wants to turn its technology into an engine for new medicines. The question now is whether — and how — it can deliver on that promise.
By Chella·1d ago
Why it mattersAn oral treatment from Gilead Sciences eliminated the symptoms experienced by patients with a type of inflammatory bowel disease, according to mid-stage study results reported Monday.
By Chella·1d ago
Why it mattersInternal emails obtained by STAT show that the American Association of Immunologists is sharply divided over California's Proposition 38, even though it would provide $8.4 billion in taxpayer dollars for…
By Chella·1d ago
Why it mattersA STAT investigation found that several nonprofits are raking in massive sums by acting as arbitrators in a program that helps protect patients from surprise medical bills.
By Chella·1d ago